In addition, the increase in glucose uptake by tumor cells results in O-GlcNAcylation of the IKKβ subunit at Ser733 causing IkB degradation, and maintaining NF-κB in the constitutively activated form in tumor cells (77). The gene discussed is NFKB1; the disease is neoplasm.